(Q43235119)

16 November 2017

title

Effect of COX-2 inhibitor after TNBS-induced colitis in Wistar rats (English)

1 reference

16 November 2017

author name string

Ana Paula Ribeiro Paiotti

1

1 reference

16 November 2017

Sender Jankiel Miszputen

2

1 reference

16 November 2017

Celina Tizuko Fujiyama Oshima

3

1 reference

16 November 2017

Henrique de Oliveira Costa

4

1 reference

16 November 2017

Daniel Araki Ribeiro

5

1 reference

16 November 2017

Marcello Franco

6

1 reference

16 November 2017

publication date

1 August 2009

1 reference

Journal of Molecular Histology

16 November 2017

published in

1 reference

16 November 2017

volume

40

1 reference

16 November 2017

issue

4

1 reference

16 November 2017

page(s)

317-324

1 reference

Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2

16 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10735-009-9243-0

Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives

21 January 2018

1 reference

12 December 2020

Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis

1 reference

12 December 2020

Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease

1 reference

12 December 2020

Epidemiology of inflammatory bowel disease

1 reference

12 December 2020

Inflammatory Bowel Disease

1 reference

12 December 2020

Selective cyclooxygenase-2 inhibitors: similarities and differences

1 reference

12 December 2020

Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression

1 reference

12 December 2020

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease

1 reference

12 December 2020

Pharmacokinetics and metabolism of lumiracoxib in healthy male subjects

1 reference

12 December 2020

Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine

1 reference

12 December 2020

Gastroduodenal tolerability of lumiracoxib vs placebo and naproxen: a pilot endoscopic study in healthy male subjects

1 reference

12 December 2020

Gastroduodenal safety and tolerability of lumiracoxib compared with Ibuprofen and celecoxib in patients with osteoarthritis.

1 reference

12 December 2020

The genetics of inflammatory bowel disease

1 reference

12 December 2020

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

1 reference

12 December 2020

COX-2-Selective NSAIDs: new and improved?

1 reference

12 December 2020

[Inflammatory bowel diseases]

1 reference

12 December 2020

Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats

1 reference

12 December 2020

Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach

1 reference

12 December 2020

The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats

1 reference

12 December 2020

Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model

1 reference

12 December 2020

Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues

1 reference

12 December 2020

Role of cyclooxygenase-2 in the healing of gastric ulcers in rats

1 reference

12 December 2020

Inflammatory bowel disease. The role of lymphotoxin in the cytotoxicity of lymphocytes for colonic epithelial cells

1 reference

12 December 2020

The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats

1 reference

12 December 2020

Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2.

1 reference

12 December 2020

Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts

1 reference

12 December 2020

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

1 reference

12 December 2020

Hyperresponsiveness of the Mucosal Barrier in Crohnʼs Disease Is Not Tumor Necrosis Factor-Dependent

1 reference

12 December 2020

Cyclooxygenase-2: a novel target for cancer chemotherapy?

1 reference

12 December 2020

Effects and mechanism of the selective COX-2 inhibitor, celecoxib, on rat colitis induced by trinitrobenzene sulfonic acid

1 reference

12 December 2020

Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats

1 reference

12 December 2020

Hapten-induced model of chronic inflammation and ulceration in the rat colon

1 reference

12 December 2020

Experimental models of inflammatory bowel disease

1 reference

12 December 2020

10.1007/S10735-009-9243-0

Identifiers

DOI

1 reference

16 November 2017

1 reference